Alignment Healthcare (ALHC) Price to Sales (2021 - 2026)

Alignment Healthcare (ALHC) has reported Price to Sales for 6 consecutive years, with 3.69 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Price to Sales rose 35.3% year-over-year to 3.69; the trailing twelve-month figure through Jun 2026 stood at 1.08 (up 29.72% YoY), and the FY2025 full-year result was 1.02, up 27.95% from the prior year.
• Price to Sales grew to 3.69 in Q2 2026 per ALHC's latest filing, from 2.95 in the prior quarter.
• Across five years, Price to Sales topped out at 6.15 in Q3 2022 and bottomed at 1.51 in Q1 2024.
• Historically, Price to Sales has averaged 3.69 across 5 years, with a median of 3.38 in 2023.
• The sharpest annual moves came in 2022 and 2025: Price to Sales plunged 60.39% in 2022, then surged 163.25% in 2025.
• Over 5 years, Price to Sales stood at 6.09 in 2022, then slumped by 42.57% to 3.5 in 2023, then fell by 11.99% to 3.08 in 2024, then increased by 29.39% to 3.98 in 2025, then dropped by 7.23% to 3.69 in 2026.
• According to Business Quant data, Price to Sales over the past three periods registered 3.69, 2.95, and 3.98 for Q2 2026, Q1 2026, and Q4 2025 respectively.